thiophenes has been researched along with Primary Hyperparathyroidism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carnevale, V; Cipriani, C; Del Fiacco, R; Fontana, A; Minisola, S; Pepe, J; Romagnoli, E | 1 |
| Fottner, C; Weber, MM | 1 |
1 review(s) available for thiophenes and Primary Hyperparathyroidism
| Article | Year |
|---|---|
[The latest developments in endocrinology 2004/2005].
Topics: Adrenal Gland Neoplasms; Adult; Bone Density Conservation Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Clinical Trials as Topic; Endocrinology; Eplerenone; Female; Humans; Hyperaldosteronism; Hyperparathyroidism; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hypogonadism; Hypothyroidism; Male; Naphthalenes; Neuroendocrine Tumors; Organometallic Compounds; Osteoporosis, Postmenopausal; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Radiography, Abdominal; Spironolactone; Teriparatide; Testosterone; Testosterone Congeners; Thiophenes; Time Factors; Tomography, X-Ray Computed | 2006 |
1 other study(ies) available for thiophenes and Primary Hyperparathyroidism
| Article | Year |
|---|---|
Effects of strontium ranelate administration on calcium metabolism in female patients with postmenopausal osteoporosis and primary hyperparathyroidism.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcifediol; Calcitriol; Calcium; Case-Control Studies; Creatinine; Dietary Supplements; Female; Humans; Hyperparathyroidism, Primary; Ions; Magnesium; Middle Aged; Organometallic Compounds; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphates; Thiophenes; Time Factors; Vitamin D | 2013 |